Anthony Petrone
Stock Analyst at Mizuho
(3.80)
# 683
Out of 4,944 analysts
191
Total ratings
51.09%
Success rate
7.61%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HAE Haemonetics | Maintains: Outperform | $90 → $70 | $53.88 | +29.92% | 15 | Aug 8, 2025 | |
| LNTH Lantheus Holdings | Maintains: Outperform | $120 → $70 | $53.79 | +30.14% | 6 | Aug 7, 2025 | |
| RMD ResMed | Maintains: Outperform | $270 → $290 | $288.28 | +0.60% | 17 | Aug 1, 2025 | |
| TFX Teleflex | Maintains: Neutral | $130 → $135 | $122.92 | +9.83% | 9 | Aug 1, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $87 → $95 | $77.68 | +22.30% | 9 | Jul 25, 2025 | |
| ABT Abbott Laboratories | Maintains: Neutral | $140 → $135 | $129.40 | +4.33% | 6 | Jul 18, 2025 | |
| COO The Cooper Companies | Maintains: Outperform | $105 → $90 | $74.27 | +21.18% | 15 | Jul 16, 2025 | |
| STAA STAAR Surgical Company | Maintains: Neutral | $17 → $18 | $28.21 | -36.19% | 8 | Jul 16, 2025 | |
| MDT Medtronic | Maintains: Outperform | $98 → $100 | $92.91 | +7.63% | 7 | Jul 16, 2025 | |
| HOLX Hologic | Maintains: Outperform | $65 → $70 | $68.98 | +1.48% | 9 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $58 → $70 | $38.34 | +82.58% | 7 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $12 | $13.94 | -13.92% | 3 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $100 | $79.96 | +25.06% | 2 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $65 | $58.57 | +10.98% | 2 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $200 → $175 | $91.79 | +90.65% | 10 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $2 | $0.48 | +314.77% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $20 | $11.13 | +79.69% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $60 | $44.91 | +33.60% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $120 | $86.48 | +38.76% | 9 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $58 | $52.72 | +10.02% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $60 | $53.06 | +13.08% | 8 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $110 | $102.50 | +7.32% | 8 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $14 | $17.20 | -18.60% | 6 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $105 | $75.33 | +39.39% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 | $87.36 | +186.17% | 6 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $7.27 | +92.57% | 4 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $350 → $390 | $482.35 | -19.15% | 6 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $63 → $67 | $95.50 | -29.84% | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $200 → $175 | $103.22 | +69.54% | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $30 → $25 | $10.69 | +133.86% | 3 | May 13, 2020 |
Haemonetics
Aug 8, 2025
Maintains: Outperform
Price Target: $90 → $70
Current: $53.88
Upside: +29.92%
Lantheus Holdings
Aug 7, 2025
Maintains: Outperform
Price Target: $120 → $70
Current: $53.79
Upside: +30.14%
ResMed
Aug 1, 2025
Maintains: Outperform
Price Target: $270 → $290
Current: $288.28
Upside: +0.60%
Teleflex
Aug 1, 2025
Maintains: Neutral
Price Target: $130 → $135
Current: $122.92
Upside: +9.83%
Edwards Lifesciences
Jul 25, 2025
Maintains: Outperform
Price Target: $87 → $95
Current: $77.68
Upside: +22.30%
Abbott Laboratories
Jul 18, 2025
Maintains: Neutral
Price Target: $140 → $135
Current: $129.40
Upside: +4.33%
The Cooper Companies
Jul 16, 2025
Maintains: Outperform
Price Target: $105 → $90
Current: $74.27
Upside: +21.18%
STAAR Surgical Company
Jul 16, 2025
Maintains: Neutral
Price Target: $17 → $18
Current: $28.21
Upside: -36.19%
Medtronic
Jul 16, 2025
Maintains: Outperform
Price Target: $98 → $100
Current: $92.91
Upside: +7.63%
Hologic
Jul 16, 2025
Maintains: Outperform
Price Target: $65 → $70
Current: $68.98
Upside: +1.48%
Jul 16, 2025
Maintains: Outperform
Price Target: $58 → $70
Current: $38.34
Upside: +82.58%
Jul 16, 2025
Maintains: Neutral
Price Target: $13 → $12
Current: $13.94
Upside: -13.92%
Jul 16, 2025
Maintains: Outperform
Price Target: $95 → $100
Current: $79.96
Upside: +25.06%
Jun 13, 2025
Maintains: Outperform
Price Target: $60 → $65
Current: $58.57
Upside: +10.98%
Apr 16, 2025
Maintains: Outperform
Price Target: $200 → $175
Current: $91.79
Upside: +90.65%
Apr 10, 2025
Initiates: Outperform
Price Target: $2
Current: $0.48
Upside: +314.77%
Apr 10, 2025
Initiates: Neutral
Price Target: $20
Current: $11.13
Upside: +79.69%
Apr 10, 2025
Initiates: Outperform
Price Target: $60
Current: $44.91
Upside: +33.60%
Mar 28, 2025
Maintains: Outperform
Price Target: $115 → $120
Current: $86.48
Upside: +38.76%
Mar 6, 2025
Maintains: Buy
Price Target: $54 → $58
Current: $52.72
Upside: +10.02%
Feb 26, 2025
Maintains: Outperform
Price Target: $70 → $60
Current: $53.06
Upside: +13.08%
Oct 24, 2024
Maintains: Outperform
Price Target: $100 → $110
Current: $102.50
Upside: +7.32%
Jun 20, 2024
Maintains: Buy
Price Target: $12 → $14
Current: $17.20
Upside: -18.60%
May 1, 2024
Maintains: Buy
Price Target: $110 → $105
Current: $75.33
Upside: +39.39%
Mar 27, 2024
Maintains: Buy
Price Target: $250
Current: $87.36
Upside: +186.17%
Mar 1, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $7.27
Upside: +92.57%
Jan 25, 2024
Maintains: Neutral
Price Target: $350 → $390
Current: $482.35
Upside: -19.15%
Aug 3, 2023
Downgrades: Hold
Price Target: $63 → $67
Current: $95.50
Upside: -29.84%
Nov 5, 2021
Maintains: Buy
Price Target: $200 → $175
Current: $103.22
Upside: +69.54%
May 13, 2020
Maintains: Hold
Price Target: $30 → $25
Current: $10.69
Upside: +133.86%